Table 2

Baseline rates of bleeding by patient characteristics

FactorMajor bleed, N (%)OR (CI)p Value
Gender
 Male565 (1.4)2.5 (2.3 to 2.9)<0.001
 Female699 (3.6)
Age
 ≤65492 (1.6)1.8 (1.6 to 2.0)<0.001
 ≥66772 (2.8)
BMI
 ≤27517 (2.7)0.7 (0.6 to 0.8)<0.001
 >27724 (1.9)
HTN
 No185 (2.1)1.0 (0.9 to 1.2)0.72
 Yes1076 (2.2)
Dyslipidemia
 No252 (3.0)0.7 (0.6 to 0.8)<0.001
 Yes1009 (2.0)
Diabetes
 No813 (2.2)0.9 (0.8 to 1.0)0.04
 Yes450 (2.0)
Prior MI
 No907 (2.4)0.7 (0.6 to 0.8)<0.001
 Yes357 (1.7)
Prior CHF
 No1029 (2.0)1.4 (1.2 to 1.6)<0.001
 Yes232 (2.8)
Prior PAD
 No1033 (2.0)1.3 (1.2 to 1.6)<0.001
 Yes228 (2.7)
Current smoker
 No855 (2.1)1.1 (1.0 to 1.3)0.05
 Yes406 (2.3)
Kidney disease
 No1220 (2.1)1.7 (1.2 to 2.4)0.002
 Yes38 (3.6)
Lung disease
 No905 (1.9)1.7 (1.5 to 1.9)<0.001
 Yes356 (3.2)
Prior PCI
 No899 (2.8)0.47 (0.42 to 0.54)<0.001
 Yes365 (1.4)
Prior CABG
 No1077 (2.3)0.64 (0.55 to 0.75)<0.001
 Yes187 (1.5)
Indication
 STEMI458 (5.8)3.03 (2.6 to 3.4)<0.001
 Non-STEMI534 (1.9)
Closure
 Compression892 (2.4)0.8 (0.7 to 1.0)0.005
 Device118 (1.9)
Anticoagulant
 Heparin922 (2.4)0.7 (0.6 to 0.7)<0.001
 Bivalirudin340 (1.6)
  • BMI, body mass index; CHF, congestive heart failure; CVD, cardiovascular disease; HTN, hypertension; MI, myocardial infarction; PAD, peripheral artery disease; PCI, percutaneous coronary intervention; STEMI, ST segment elevation myocardial infarction.